Clinical Trials Logo

Clinical Trial Summary

Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique. study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator. The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone. conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department.


Clinical Trial Description

Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique. study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator. The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone. conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03995199
Study type Observational
Source AZ Sint-Jan AV
Contact Araceli Diez-Fraile
Phone +32 5045 9660
Email araceli.diez-fraile@azsintjan.be
Status Recruiting
Phase
Start date September 13, 2017
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT03688737 - Low Level Laser in Isolated Cleft Palate Repair Versus Surgical Correction Without LLL in Healing Process N/A
Recruiting NCT06105099 - Effect of Performance-specific Cleft Speech Intervention and Long-term Learning in Children With a Cleft Palate N/A
Active, not recruiting NCT03799068 - Suprazygomatic Nerve Block vs Surgical Site Infiltration in Cleft Palate Repair N/A
Recruiting NCT06143254 - Effect of Infant Sign Training on Speech-language Development N/A
Completed NCT03994679 - Feasibility and Performance of Virtual Software for Virtual Bone Graft Planning in Cleft Patients
Enrolling by invitation NCT04909619 - Suprazygomatic Maxillary Nerve Block in Cleft Palate Outcomes N/A
Recruiting NCT05331456 - Alveolar Cleft Repair Using Osteoinductive Ceramics N/A
Not yet recruiting NCT06381713 - Effect and Cost-utility of of High Intensity vs. Low Intensity Speech Intervention in Children With Cleft Palate N/A